Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 11.25mg	11.25mg	Injectable powder for suspension+diluent	31,761,098 L.L
L02AE04	DECAPEPTYL LP	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	11,778,312 L.L
L02AE04	DECAPEPTYL	B	Triptorelin - 0.1mg	0.1mg	Injectable lyophilised powder for solution+diluent	2,366,507 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 1800mg	1800mg	Injectable solution	514,508,612 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 400mg/20ml	400mg/20ml	Injectable concentrate for solution	171,503,274 L.L
L01EL01	DULLARMA	G	Ibrutinib - 140mg	140mg	Capsule, hard	422,860,803 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 140mg	140mg	Tablet, film coated	127,364,905 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 140mg	140mg	Tablet, film coated	254,729,810 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 20mg	20mg	Tablet, film coated	103,165,573 L.L
L01EA02	DALEUBIN	G	Dasatinib - 20mg	20mg	Tablet, film coated	82,387,571 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 50mg	50mg	Tablet, film coated	127,364,905 L.L
L01EA02	DALEUBIN	G	Dasatinib - 50mg	50mg	Tablet, film coated	101,548,596 L.L
L01EA02	DASATINIB NEAPOLIS	G	Dasatinib - 70mg	70mg	Tablet, film coated	127,364,905 L.L
L01EA02	DALEUBIN	G	Dasatinib - 70mg	70mg	Tablet, film coated	102,415,923 L.L
L01DB01	DOXORUBICINE EBEWE	G	Doxorubicin HCl - 2mg/ml	50mg/25ml	Injectable concentrated solution	1,804,780 L.L
L01DB01	DOXORUBICINA PHARMINICIO	G	Doxorubicin HCl - 50mg/25ml	50mg/25ml	Injectable concentrate for solution	2,015,764 L.L
L01DB01	DOXO-CELL	G	Doxorubicin HCl - 50mg/25ml	50mg/25ml	Injectable solution	1,794,030 L.L
L01DB01	DOXORUBICINE EBEWE	G	Doxorubicin HCl - 10mg/5ml	10mg/5ml	Injectable concentrated solution	428,686 L.L
L01CD02	DOCETAXEL GP PHARM	G	Docetaxel - 40mg/ml	20mg/0.5ml	Injectable concentrated solution+diluent	4,567,721 L.L
L01CD02	DOCETAXEL EBEWE	G	Docetaxel - 20mg/2ml	20mg/2ml	Injectable solution	5,313,553 L.L
L01CD02	DOCETAXEL ACCORD	G	Docetaxel - 20mg/ml	20mg/1ml	Injectable concentrate for solution	4,110,814 L.L
L01CD02	DOCETAXEL SPC	G	Docetaxel - 80mg/4ml	80mg/4ml	Injectable concentrate for solution	16,906,027 L.L
L01CD02	DOCETAXEL GP PHARM	G	Docetaxel - 40mg/ml	80mg/2ml	Injectable concentrated solution+diluent	16,777,239 L.L
L01CD02	DOCETAXEL EBEWE	G	Docetaxel - 80mg/8ml	80mg/8ml	Injectable solution	19,518,281 L.L
L01CD02	DOCETAXEL ACCORD	G	Docetaxel - 80mg/4ml	80mg/4ml	Injectable concentrate for solution	15,099,641 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	90,495,926 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	90,495,926 L.L
L01BC06	DIROGIT	G	Capecitabine - 500mg	500mg	Tablet, film coated	11,330,804 L.L
L01AX04	DACARBAZINE MEDAC	G	Dacarbazine - 1,000mg	1,000mg	Injectable powder for solution	5,411,654 L.L
L01AX04	DACARBAZINE MEDAC	G	Dacarbazine - 200mg	200mg	Injectable powder for solution	15,866,076 L.L

...